Skip to content

Individual and Family Therapy for Children With Anxiety Disorders

Child and Family Therapy for Anxiety-Disordered Youth

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00081406
Enrollment
150
Registered
2004-04-12
Start date
2000-07-31
Completion date
Unknown
Last updated
2014-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

The purpose of this study is to compare three treatments to determine which is most effective in reducing anxiety in children.

Detailed description

Children and their parents will complete a comprehensive diagnostic assessment to determine eligibility. The assessment will include an individual diagnostic interview with the child, interviews with the parents, and written observations of the child from family members and teachers. Participants will then be randomly assigned to receive individual cognitive behavioral therapy (ICBT), family CBT (FCBT), or education/support/attention (ESA) for 5 months. Children in the ICBT group will meet individually with a therapist. In the FCBT and ESA treatment groups, children and their parents will meet weekly with a therapist. At the end of treatment and 1 year following treatment completion, families will complete another assessment to determine the effectiveness of each treatment at reducing short- and long-term anxiety symptoms in their children.

Interventions

BEHAVIORALFamily CBT
BEHAVIORALEducation/Support/Attention

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Temple University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* Child with DSM-IV criteria for separation anxiety disorder, social phobia, or generalized anxiety disorder

Exclusion criteria

for Child Participants: * IQ less than 80 * Current use of anti-anxiety or antidepressant medications * Psychotic symptoms * Child and/or parent is non-English speaking

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026